Abstract
Liquid metal (LM) offers a novel approach to cancer therapy and imaging. By injecting a gallium-based alloy into interstitial channels, researchers have demonstrated that LM can encapsulate transplanted hepatoma tumors, physically inhibiting their growth. Furthermore, LM serves as a dual-modality contrast agent, enhancing T2-weighted MRI and Magneto-acoustic tomography (MAT) to better define tumor boundaries. This study evaluates the efficacy, imaging potential, and biocompatibility of LM in a mouse model.
Introduction
Hepatocellular carcinoma (HCC) is a significant global health challenge, frequently requiring surgical intervention. The success of such surgeries often hinges on the precise identification of the Negative Resection Margin (NRM)—the boundary between cancerous and healthy tissue. Current imaging techniques like standard MRI often lack the contrast necessary to delineate this margin clearly, leading to risks of incomplete removal or excessive tissue loss.
Beyond imaging, there is a growing need for interventional therapies that can suppress tumor growth locally without the systemic toxicity of chemotherapy. Gallium-based liquid metals, known for their fluidity, high conductivity, and radiopacity, present a unique opportunity to address both imaging and therapeutic needs simultaneously.
Methods
The study utilized a gallium-indium alloy (75% Ga, 25% In) that remains liquid at room temperature. Fifty BALB/c-nude female mice with transplanted HepG2-type tumors were divided into three groups: LM-treated, PBS (saline) control, and an untreated control.
Interstitial Injection and Delivery
Unlike traditional intravenous delivery, the researchers employed interstitial injection into the fascia spaces of the mice's forelimbs. This method leverages natural anatomical "channels" to guide the LM toward the tumor site.
Imaging and Evaluation
Tumor progression was monitored over a 12-day period using T2-weighted MRI (T2WI) and Magneto-acoustic tomography (MAT). MAT is an emerging technique where magnetic induction generates acoustic signals, which is highly sensitive to the electrical conductivity provided by the LM. Post-study, histopathological and biochemical analyses (ALT, AST, Urea) were conducted to evaluate the material's biocompatibility and systemic impact.
Results and Discussion
Tumor Growth Inhibition via Encapsulation
The most striking therapeutic finding was the "wrapping" effect. Upon reaching the tumor site via interstitial channels, the liquid metal tended to encase the tumor surface. This physical barrier effectively blocked the transport of essential nutrients from the surrounding healthy tissue, "starving" the hepatoma.
Quantitative analysis confirmed this effect. By Day 12, the tumor volume ratio in the LM group (~9.2) was significantly lower than in the PBS group (~15.7) and the Control group (~17.5).
Enhanced Imaging Contrast
The LM acted as a powerful contrast agent for both MRI and MAT. In T2-weighted MRI, the LM appeared as a sharp, dark boundary against the tumor tissue, providing a clear visual marker for the NRM. In MAT imaging, the high electrical conductivity of the gallium alloy dramatically increased signal amplitude, allowing for high-resolution visualization of the tumor's cross-sectional profile that is otherwise difficult with low-conductivity biological tissues.
Biocompatibility and Safety
Biochemical markers for liver and kidney stress (ALT and AST) were notably lower in the LM group compared to other tumor-bearing groups. This suggests that by successfully inhibiting tumor growth, the LM treatment reduced the overall systemic burden on the mice. However, histopathology did reveal mild local inflammation and cytoplasmic swelling in some organs, indicating that while the treatment is generally well-tolerated, the long-term metabolic fate of gallium requires further investigation.
Conclusion
This research demonstrates that interstitial injection of liquid metal is a promising "two-in-one" strategy for cancer management. It provides a physical means of tumor suppression while simultaneously offering superior imaging contrast for surgical planning. Future work will focus on improving the completeness of tumor encapsulation and testing the delivery method in orthotopic liver tumor models.
Summary updated